Re-Pharm is an early-stage drug discovery and development company based on the principles of compound re-profiling. Our goal is to identify compounds currently on the market, or previously failed to make it to market for commercial reasons, and re-purpose them to address diseases in areas of unmet medical need.
State of Ownership
Former Head of Communities, Springer Nature
Chief Product Officer, Zapnito
CEO & Co-Founder, Zapnito
Sales Account Executive, Springer Nature